Monoclonal Antibodies for the Treatment of Nasal Polyps.

Related Articles

Monoclonal Antibodies for the Treatment of Nasal Polyps.

Immunol Allergy Clin North Am. 2017 May;37(2):357-367

Authors: Willson TJ, Naclerio RM, Lee SE

Abstract
Biologics are novel therapeutic medications developed for the targeted therapy for a variety of inflammatory conditions. The biologics currently investigated for the treatment of chronic rhinosinusitis (CRS) with nasal polyps modulate specific inflammatory pathways involved in the pathogenesis of disease. Investigations have focused on the most severe form of the disease, namely, CRS with nasal polyps. It is hoped that specific targeted therapies using these biologics can significantly modulate the immune system, offering both disease control and symptomatic relief. This review summarizes those therapies that have been used to treat nasal polyps.

PMID: 28366482 [PubMed - in process]

http://ift.tt/2oGXfFh